A detailed history of California State Teachers Retirement System transactions in Novo Cure LTD stock. As of the latest transaction made, California State Teachers Retirement System holds 97,024 shares of NVCR stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
97,024
Previous 99,606 2.59%
Holding current value
$1.61 Million
Previous $1.71 Million 11.14%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.61 - $23.34 $40,305 - $60,263
-2,582 Reduced 2.59%
97,024 $1.52 Million
Q2 2024

Aug 14, 2024

SELL
$11.83 - $24.05 $27,824 - $56,565
-2,352 Reduced 2.31%
99,606 $1.71 Million
Q1 2024

May 15, 2024

SELL
$12.42 - $17.29 $70,620 - $98,310
-5,686 Reduced 5.28%
101,958 $1.59 Million
Q4 2023

Feb 13, 2024

SELL
$11.13 - $15.78 $54,926 - $77,874
-4,935 Reduced 4.38%
107,644 $1.61 Million
Q3 2023

Nov 14, 2023

SELL
$16.15 - $42.35 $722,211 - $1.89 Million
-44,719 Reduced 28.43%
112,579 $1.82 Million
Q2 2023

Aug 21, 2023

SELL
$40.29 - $82.51 $162,126 - $332,020
-4,024 Reduced 2.49%
157,298 $6.53 Million
Q1 2023

May 09, 2023

SELL
$56.44 - $118.81 $86,748 - $182,610
-1,537 Reduced 0.94%
161,322 $9.7 Million
Q4 2022

Feb 14, 2023

BUY
$63.98 - $85.37 $184,070 - $245,609
2,877 Added 1.8%
162,859 $11.9 Million
Q3 2022

Nov 18, 2022

SELL
$67.99 - $89.57 $119,050 - $156,837
-1,751 Reduced 1.08%
159,982 $12.2 Million
Q2 2022

Aug 15, 2022

BUY
$56.6 - $89.9 $59,316 - $94,215
1,048 Added 0.65%
161,733 $11.2 Million
Q1 2022

May 16, 2022

SELL
$60.15 - $84.52 $612,086 - $860,075
-10,176 Reduced 5.96%
160,685 $13.3 Million
Q4 2021

Feb 15, 2022

SELL
$75.08 - $121.99 $58,036 - $94,298
-773 Reduced 0.45%
170,861 $12.8 Million
Q3 2021

Nov 15, 2021

SELL
$116.17 - $194.55 $1.47 Million - $2.46 Million
-12,657 Reduced 6.87%
171,634 $19.9 Million
Q2 2021

Aug 16, 2021

SELL
$130.4 - $225.58 $786,964 - $1.36 Million
-6,035 Reduced 3.17%
184,291 $40.9 Million
Q1 2021

May 18, 2021

BUY
$124.11 - $190.17 $17,375 - $26,623
140 Added 0.07%
190,326 $25.2 Million
Q4 2020

Feb 16, 2021

BUY
$112.16 - $174.14 $1.66 Million - $2.58 Million
14,828 Added 8.46%
190,186 $32.9 Million
Q3 2020

Nov 17, 2020

BUY
$58.05 - $111.31 $245,725 - $471,175
4,233 Added 2.47%
175,358 $19.5 Million
Q2 2020

Aug 17, 2020

BUY
$57.2 - $74.41 $2.24 Million - $2.91 Million
39,086 Added 29.6%
171,125 $10.1 Million
Q1 2020

May 13, 2020

SELL
$57.05 - $95.75 $37,310 - $62,620
-654 Reduced 0.49%
132,039 $8.89 Million
Q4 2019

Feb 14, 2020

SELL
$68.3 - $93.8 $183,044 - $251,384
-2,680 Reduced 1.98%
132,693 $11.2 Million
Q3 2019

Nov 15, 2019

BUY
$61.86 - $97.8 $303,114 - $479,220
4,900 Added 3.76%
135,373 $10.1 Million
Q2 2019

Aug 14, 2019

BUY
$42.22 - $63.23 $751,136 - $1.12 Million
17,791 Added 15.79%
130,473 $8.25 Million
Q1 2019

May 09, 2019

SELL
$31.96 - $56.12 $82,616 - $145,070
-2,585 Reduced 2.24%
112,682 $5.43 Million
Q4 2018

Feb 13, 2019

BUY
$28.72 - $52.63 $76,883 - $140,890
2,677 Added 2.38%
115,267 $3.86 Million
Q3 2018

Nov 14, 2018

BUY
$32.0 - $52.4 $84,256 - $137,969
2,633 Added 2.39%
112,590 $5.9 Million
Q2 2018

Aug 14, 2018

BUY
$19.85 - $32.0 $412,562 - $665,088
20,784 Added 23.31%
109,957 $3.44 Million
Q1 2018

May 15, 2018

SELL
$19.3 - $23.65 $36,148 - $44,296
-1,873 Reduced 2.06%
89,173 $1.94 Million
Q4 2017

Feb 14, 2018

SELL
$16.3 - $21.9 $23,194 - $31,163
-1,423 Reduced 1.54%
91,046 $1.84 Million
Q3 2017

Nov 13, 2017

BUY
$18.05 - $21.75 $1.67 Million - $2.01 Million
92,469
92,469 $1.84 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.74B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.